Market Closed -
Australian S.E.
10:40:47 29/02/2024 am IST
|
5-day change
|
1st Jan Change
|
0.062
AUD
|
-1.59%
|
|
-.--%
|
-36.08%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
488.4
|
277.9
|
112.9
|
94.49
|
96.62
|
46.63
|
Enterprise Value (EV)
1 |
408.8
|
231.5
|
120.7
|
92.07
|
141.9
|
106.8
|
P/E ratio
|
-92.8
x
|
-25.1
x
|
-6.63
x
|
-3.49
x
|
-3.48
x
|
-1.32
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
325
x
|
107
x
|
70.6
x
|
11.1
x
|
8.6
x
|
2.26
x
|
EV / Revenue
|
272
x
|
88.8
x
|
75.4
x
|
10.8
x
|
12.6
x
|
5.18
x
|
EV / EBITDA
|
-106
x
|
-21.4
x
|
-8.24
x
|
-5.31
x
|
-7.17
x
|
-5.89
x
|
EV / FCF
|
-53
x
|
-7.79
x
|
-2.55
x
|
-2.83
x
|
-2.56
x
|
-8.17
x
|
FCF Yield
|
-1.89%
|
-12.8%
|
-39.2%
|
-35.3%
|
-39.1%
|
-12.2%
|
Price to Book
|
5.69
x
|
3.6
x
|
1.85
x
|
1.03
x
|
1.14
x
|
0.79
x
|
Nbr of stocks (in thousands)
|
1,39,547
|
1,41,804
|
1,42,892
|
2,77,912
|
3,51,355
|
3,88,615
|
Reference price
2 |
3.500
|
1.960
|
0.7900
|
0.3400
|
0.2750
|
0.1200
|
Announcement Date
|
22/08/18
|
27/08/19
|
26/08/20
|
22/08/21
|
28/08/22
|
27/08/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1.503
|
2.608
|
1.6
|
8.527
|
11.24
|
20.63
|
EBITDA
1 |
-3.871
|
-10.82
|
-14.65
|
-17.34
|
-19.79
|
-18.13
|
EBIT
1 |
-4.717
|
-12.37
|
-16.33
|
-19.31
|
-24.25
|
-29.73
|
Operating Margin
|
-313.79%
|
-474.4%
|
-1,020.99%
|
-226.47%
|
-215.76%
|
-144.06%
|
Earnings before Tax (EBT)
1 |
-4.726
|
-10.93
|
-16.94
|
-25.1
|
-26.47
|
-33.79
|
Net income
1 |
-4.726
|
-10.93
|
-16.94
|
-25.1
|
-26.47
|
-33.79
|
Net margin
|
-314.35%
|
-418.96%
|
-1,058.85%
|
-294.39%
|
-235.52%
|
-163.76%
|
EPS
2 |
-0.0377
|
-0.0782
|
-0.1191
|
-0.0975
|
-0.0790
|
-0.0908
|
Free Cash Flow
1 |
-7.714
|
-29.73
|
-47.26
|
-32.5
|
-55.53
|
-13.07
|
FCF margin
|
-513.12%
|
-1,139.9%
|
-2,954.21%
|
-381.14%
|
-494.1%
|
-63.36%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/08/18
|
27/08/19
|
26/08/20
|
22/08/21
|
28/08/22
|
27/08/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
7.77
|
-
|
45.3
|
60.2
|
Net Cash position
1 |
79.6
|
46.4
|
-
|
2.43
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.5304
x
|
-
|
-2.286
x
|
-3.321
x
|
Free Cash Flow
1 |
-7.71
|
-29.7
|
-47.3
|
-32.5
|
-55.5
|
-13.1
|
ROE (net income / shareholders' equity)
|
-9.4%
|
-13.4%
|
-24.5%
|
-32.8%
|
-29.9%
|
-46.9%
|
ROA (Net income/ Total Assets)
|
-5.79%
|
-9.16%
|
-12.9%
|
-13.5%
|
-12.6%
|
-13.8%
|
Assets
1 |
81.64
|
119.3
|
131.5
|
185.3
|
210.9
|
244.7
|
Book Value Per Share
2 |
0.6200
|
0.5500
|
0.4300
|
0.3300
|
0.2400
|
0.1500
|
Cash Flow per Share
2 |
0.3600
|
0.3300
|
0.0100
|
0.0100
|
0.0100
|
0
|
Capex
1 |
5.58
|
25.3
|
33.1
|
15.7
|
45.2
|
3.1
|
Capex / Sales
|
371.12%
|
971.08%
|
2,070.66%
|
184.26%
|
401.89%
|
15.03%
|
Announcement Date
|
22/08/18
|
27/08/19
|
26/08/20
|
22/08/21
|
28/08/22
|
27/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -36.08% | 1.79Cr | | -.--% | 34Cr | | +32.99% | 28Cr | | +45.93% | 18Cr | | +156.53% | 15Cr | | -35.82% | 14Cr | | +47.09% | 14Cr | | -42.86% | 12Cr | | +11.54% | 8.03Cr | | +10.00% | 6.03Cr |
Medical Farming
|